Terms: = Lung cancer AND CgA AND Treatment
78 results:
1. Efficacy of immune checkpoint inhibitors in SMARCA4-deficient and TP53 mutant undifferentiated lung cancer.
Chen J; Zheng Q; Wang J; Zhang X; Lv Y
Medicine (Baltimore); 2024 Feb; 103(8):e36959. PubMed ID: 38394494
[TBL] [Abstract] [Full Text] [Related]
2. Synchronous double primary small cell lung cancer and invasive ductal breast carcinoma: a case report.
Gan J; Liu M; Liu F; Wen J; Fu W; Jia J
BMC Pulm Med; 2024 Feb; 24(1):93. PubMed ID: 38388422
[TBL] [Abstract] [Full Text] [Related]
3. Clinicopathological features and differential diagnosis of gastric metastases.
Chen W; Liu C; Liu Y; Yuan J; Wang Z
World J Surg Oncol; 2023 Aug; 21(1):258. PubMed ID: 37608278
[TBL] [Abstract] [Full Text] [Related]
4. Clinicopathological features, treatment modalities, and prognosis of esophageal neuroendocrine carcinoma: A single-center retrospective study.
Zhang Y; Liao JT; Lin Y; Liu C; Wu ZH; Yu B; Sun S; Yu H; Hui XH; Wu XH; Zhao XM; Wang HJ; Zheng Q; Li Y; Hu ZH; Wang JL
J Dig Dis; 2023; 24(8-9):472-479. PubMed ID: 37596865
[TBL] [Abstract] [Full Text] [Related]
5. The effect of comprehensive geriatric assessment on care received, treatment completion, toxicity, cancer-related and geriatric assessment outcomes, and quality of life for older adults receiving systemic anti-cancer treatment: A systematic review.
Disalvo D; Moth E; Soo WK; Garcia MV; Blinman P; Steer C; Amgarth-Duff I; Power J; Phillips J; Agar M
J Geriatr Oncol; 2023 Nov; 14(8):101585. PubMed ID: 37573197
[TBL] [Abstract] [Full Text] [Related]
6. Metastases to the kidney from primary lung cancer : clinicopathological analysis of six cases in a single center.
Lian H; Pan X; Hong B; Min J; Huang F
Diagn Pathol; 2023 May; 18(1):60. PubMed ID: 37161448
[TBL] [Abstract] [Full Text] [Related]
7. [Mucinous tubular and spindle cell carcinoma of kidney: Clinicopathology and prognosis].
Shen Q; Liu YX; He Q
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):276-282. PubMed ID: 37042138
[TBL] [Abstract] [Full Text] [Related]
8. The prognostic value of comprehensive geriatric assessment on the management of older patients with small cell lung cancer.
Chun YJ; Kim KJ; Lee JY; Choi JW; Kim TH; Kim HR; Cho BC; Hong MH; Kim CO
Korean J Intern Med; 2023 Mar; 38(2):254-263. PubMed ID: 36650729
[TBL] [Abstract] [Full Text] [Related]
9. Plasma Progastrin-Releasing Peptide and Chromogranin A Assays for Diagnosing and Monitoring lung Well-Differentiated Neuroendocrine Tumors: A Brief Report.
Nisman B; Oleinikov K; Nechushtan H; Maimon O; Atlan K; Peled N; Gross D; Peretz T; Meirovitz A; Grozinsky-Glasberg S
J Thorac Oncol; 2023 Mar; 18(3):369-376. PubMed ID: 36503175
[TBL] [Abstract] [Full Text] [Related]
10. Pulmonary Large Cell Neuroendocrine Carcinoma.
Yang L; Fan Y; Lu H
Pathol Oncol Res; 2022; 28():1610730. PubMed ID: 36304941
[TBL] [Abstract] [Full Text] [Related]
11. The association between geriatric assessment, muscle measures, and treatment-related toxicity in older adults with cancer: An Israeli prospective study.
Shachar SS; Bar-Sela G; Peer A; Moskovitz MT; Bareket-Samish A; Epstein J; Wollner M; Shafran I; Boukal A; Williams GR
J Geriatr Oncol; 2022 Nov; 13(8):1203-1207. PubMed ID: 35989184
[TBL] [Abstract] [Full Text] [Related]
12. [On detection of chromogranin A, synaptophysin, neuronspecific enolase and progastrin-releasing peptide in small cell lung cancer].
Lu QQ; Li J; Li YH; Liu H; Xie XB
Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Jul; 56(7):1017-1022. PubMed ID: 35899358
[TBL] [Abstract] [Full Text] [Related]
13. Functional status in older patients with lung cancer: an observational cohort study.
Couderc AL; Tomasini P; Greillier L; Nouguerède E; Rey D; Montegut C; Thomas PA; Barlesi F; Villani P
Support Care Cancer; 2022 May; 30(5):3817-3827. PubMed ID: 35031829
[TBL] [Abstract] [Full Text] [Related]
14. Clinical characteristics and prognostic model for extensive-stage small cell lung cancer: A retrospective study over an 8-year period.
Ni J; Zhang X; Wang H; Si X; Xu Y; Zhao J; Chen M; Zhang L; Wang M
Thorac Cancer; 2022 Feb; 13(4):539-548. PubMed ID: 34970848
[TBL] [Abstract] [Full Text] [Related]
15. Neuroendoscopic surgery for neuroendocrine cancer of the skull base.
Qin X; Hong T; Shen X; Liu Q
Neuro Endocrinol Lett; 2021 Jan; 41(6):296-300. PubMed ID: 33714241
[TBL] [Abstract] [Full Text] [Related]
16. Cytological Features of Pulmonary Papillary Adenoma with Malignant Transformation and Literature Review.
Hu X; Chen Y; Ru G; Yu L
Anal Cell Pathol (Amst); 2020; 2020():8827056. PubMed ID: 33282636
[TBL] [Abstract] [Full Text] [Related]
17. Octogenarians treated for thoracic and lung cancers: Impact of comprehensive geriatric assessment.
Couderc AL; Tomasini P; Rey D; Nouguerède E; Correard F; Barlesi F; Thomas P; Villani P; Greillier L
J Geriatr Oncol; 2021 Apr; 12(3):402-409. PubMed ID: 33097456
[TBL] [Abstract] [Full Text] [Related]
18. Older Patients Treated for lung and Thoracic cancers: Unplanned Hospitalizations and Overall Survival.
Couderc AL; Tomasini P; Nouguerède E; Rey D; Correard F; Montegut C; Thomas PA; Villani P; Barlesi F; Greillier L
Clin Lung Cancer; 2021 May; 22(3):e405-e414. PubMed ID: 32665168
[TBL] [Abstract] [Full Text] [Related]
19. Molecular identification of bronchopulmonary neuroendocrine tumours and neuroendocrine genotype in lung neoplasia using the NETest liquid biopsy.
Filosso PL; Öberg K; Malczewska A; Lewczuk A; Roffinella M; Aslanian H; Bodei L
Eur J Cardiothorac Surg; 2020 Jun; 57(6):1195-1202. PubMed ID: 32047924
[TBL] [Abstract] [Full Text] [Related]
20. PRRT neuroendocrine tumor response monitored using circulating transcript analysis: the NETest.
Bodei L; Kidd MS; Singh A; van der Zwan WA; Severi S; Drozdov IA; Malczewska A; Baum RP; Kwekkeboom DJ; Paganelli G; Krenning EP; Modlin IM
Eur J Nucl Med Mol Imaging; 2020 Apr; 47(4):895-906. PubMed ID: 31838581
[TBL] [Abstract] [Full Text] [Related]
[Next]
